Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Prepaid Assets (2016 - 2025)

Sunshine Biopharma's Prepaid Assets history spans 14 years, with the latest figure at $105345.0 for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 90.7% year-over-year to $105345.0; the TTM value through Dec 2025 reached $105345.0, down 90.7%, while the annual FY2025 figure was $105345.0, 90.7% down from the prior year.
  • Prepaid Assets reached $105345.0 in Q4 2025 per SBFM's latest filing, down from $441489.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.8 million in Q2 2024 to a low of $10993.0 in Q1 2021.
  • Average Prepaid Assets over 5 years is $403696.6, with a median of $129642.5 recorded in 2023.
  • Peak YoY movement for Prepaid Assets: surged 1859.2% in 2024, then tumbled 90.7% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $29625.0 in 2021, then surged by 857.97% to $283799.0 in 2022, then rose by 9.44% to $310591.0 in 2023, then soared by 264.88% to $1.1 million in 2024, then crashed by 90.7% to $105345.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Prepaid Assets are $105345.0 (Q4 2025), $441489.0 (Q3 2025), and $939436.0 (Q2 2025).